Cobo Dols News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non–Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study

Sandip P. Patel, MD, reviews data from the preliminary results of the EVOKE-02 study investigating sacituzumab govitecan plus pembrolizumab in first-line metastatic non–small cell lung cancer.

United statesCobo dolsSacituzumab govitecanReyes cabanillasSandipp patelMetastatic nonSmall cell lung cancerPreliminary resultsPartnership withWorld conferenceLung cancerNon small cell lung cancerMetastatic non small cell lung cancerMetastatic nsclcEvoke 02Pd l1 inhibitor

Several Research Avenues Are Available for Improving Response to Immunotherapy in Advanced NSCLC

Tony S.K. Mok, MD, BMSc, FRCPC, FASCO, highlights novel partners and potential new approaches for immunotherapy-based regimens for the treatment of patients with non–small cell lung cancer.

United statesEli lillyCobo dolsMerck seronoRoche genentechTonys mokBristol myers squibbChinese university of hong kongVertex pharmaceuticalsSanomics ltdInternational lung cancer congressBoehringer ingelheimChinese lung cancer research foundation ltdClinical oncologyChinese universityHong kong

TTFields Highlight Novel Immunotherapy Combination Approaches in Advanced NSCLC

TTFields Highlight Novel Immunotherapy Combination Approaches in Advanced NSCLC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesRoche genentechBristol myers squibbCobo dolsEli lillyTony sk mokMerck seronoChinese university of hong kongInternational lung cancer congressChinese lung cancer research foundation ltdSanomics ltdBoehringer ingelheimVertex pharmaceuticalsClinical oncologyChinese universityHong kong